This text has been automatically translated, it may contain errors or inaccuracies.
Health
Favorite
Remove from my list

Osakidetza has launched the first state study for early detection of type 1 diabetes in the pediatric population

More than 6,000 people will participate in the work led by the Basque Country. Sintoma Clinic aims to identify the disease before it appears and thus reduce complications and enable it to act beforehand.

A boy with diabetes, in a stock image of EITB Media.

The Department of Health of the Basque Government and Osakidetza have launched a new study that has made the Basque Country the first community in the Spanish State to implement a pilot screening project for early detection of type 1 diabetes in the paediatric population, a disease that usually appears in children and adolescents and that in 35% of cases is accompanied by diabetic ketoacidosis, a study aimed at preventing this serious complication.

The SCREEND1A initiative, which covers more than 6,000 people , includes both the general paediatric population and first-degree relatives of people with type 1 diabetes. The aim is to detect the disease beforethe first clinical symptoms appear, so that it can act beforehand, improve prognosis and provide adequate education and training to families and patients.

Screening is intended to intervene at an early stage , that is, when reserves of pancreatic cells that produce insulin are still preserved. This could make it possible to apply new therapies and significantly improve the evolution ofthe disease. Moreover, advanced detection is thought to significantly reduce the need for urgent care and hospitalization, as it would avoid a serious clinical debut. It would also facilitate better glycemic control from the outset.

6,000 participants.

The study is divided into two lines of action, one of which contains a prospective design of the general paediatric population, the first of its kind to be carried out in the State, and which will accommodate 4,000 children between the ages of 3 and 13. Samples are taken in paediatric examinations at health centres in Álava, Bizkaia and Gipuzkoa.

The second line has a prospective and retrospective view of first-degree family members in patients with type 1 diabetes, both adults and minors. This part of the study envisages 2,000 participants and is carried out in Pediatric Endocrinology and Endocrinology and Nutrition consultations in hospitals in the three territories.

Once the conclusions have been received, Osakidetza will assess the scalability of the strategy, which could be implemented as a new screening in the health system and open the door to emerging therapies in the early stages of the disease.

You might like

Load more